Quest Diagnostics earnings were $897.0M for the trailing 12 months ending Mar 31, 2025, with 6.4% growth year over year. The latest DGX earnings report on Mar 31, 2025 announced Q1 2025 earnings of $220.0M, down 0.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, DGX reported annual earnings of $871.0M, with 2% growth.
DGX past earnings growth
How has DGX's earnings growth performed historically?
What were Quest Diagnostics's earnings last quarter?
On DGX's earnings call on Invalid Date, Quest Diagnostics (NYSE: DGX) reported Q1 2025 earnings per share (EPS) of $1.97, up 13.22% year over year. Total DGX earnings for the quarter were $220.00 million. In the same quarter last year, Quest Diagnostics's earnings per share (EPS) was $1.74.
As of the last Quest Diagnostics earnings report, Quest Diagnostics is currently profitable. Quest Diagnostics's net profit (also called net income) for the twelve months ending Mar 31, 2025 was $897.00 million, a 6.03% increase year over year.
What was DGX's earnings growth in the past year?
As of Quest Diagnostics's earnings date in Invalid Date, Quest Diagnostics's earnings has grown 6.37% year over year. This is 6.72 percentage points higher than the US Diagnostics & Research industry earnings growth rate of -0.34%. DGX earnings in the past year totalled $897.00 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.